News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,344 Results
Type
Article (8624)
Company Profile (141)
Press Release (477482)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (167481)
Career Advice (325)
Deals (25968)
Drug Delivery (7)
Drug Development (53119)
Employer Resources (15)
FDA (9834)
Job Trends (8750)
News (239309)
Policy (18091)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (1)
Academia (492)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33261)
ALS (104)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (269)
Approvals (10456)
Artificial intelligence (320)
ASCO (160)
Autoimmune disease (205)
Automation (28)
Bankruptcy (263)
Best Places to Work (7122)
BIO (36)
BIOSECURE Act (1)
Biosimilars (110)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (506)
Cancer (3642)
Cardiovascular disease (217)
Career advice (262)
Career pathing (1)
CAR-T (173)
Celiac Disease (1)
Cell therapy (478)
Cervical cancer (34)
Clinical research (48046)
Collaboration (1241)
Commercialization (3)
Compensation (1444)
Complete response letters (35)
COVID-19 (758)
CRISPR (63)
C-suite (741)
Cystic fibrosis (85)
Data (5622)
Denatured (4)
Depression (104)
Dermatology (62)
Diabetes (341)
Diagnostics (4176)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (8)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73698)
Editorial (2)
Employer branding (2)
Employer resources (15)
Events (87841)
Executive appointments (706)
FDA (12460)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (911)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (292)
Government (982)
Grass and pollen (2)
Guidances (283)
Healthcare (9329)
Hematology (99)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (156)
Infectious disease (946)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (43)
IPO (12429)
IRA (2)
Job creations (2009)
Job search strategy (252)
JPM (3)
Kidney cancer (16)
Layoffs (71)
Legal (5258)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (503)
Lymphoma (254)
Machine learning (27)
Management (3)
Manufacturing (532)
Marketing (8)
MASH (118)
Medical device (8656)
Medtech (8796)
Mergers & acquisitions (14574)
Metabolic disorders (706)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (221)
Neuropsychiatric disorders (38)
Neuroscience (1829)
NextGen: Class of 2026 (3195)
Non-profit (848)
Now hiring (1)
Obesity (223)
Opinion (18)
Ovarian cancer (161)
Pain (171)
Pancreatic cancer (195)
Parkinson's disease (205)
Partnered (12)
Patents (472)
Patient recruitment (501)
Peanut (31)
People (41455)
Pharmaceutical (31)
Pharmacy benefit managers (8)
Phase 1 (15485)
Phase 2 (21450)
Phase 3 (14529)
Pipeline (7176)
Policy (19)
Postmarket research (1573)
Preclinical (6552)
Press Release (34)
Prostate cancer (190)
Psychedelics (7)
Radiopharmaceuticals (190)
Rare diseases (569)
Real estate (3050)
Recruiting (7)
Regulatory (14909)
Reports (19)
Research institute (583)
Resumes & cover letters (47)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (154)
Series B (120)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2049)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (18)
Weight loss (75)
Women's health (78)
Date
Today (93)
Last 7 days (542)
Last 30 days (1617)
Last 365 days (19239)
2026 (11948)
2025 (19325)
2024 (23067)
2023 (26618)
2022 (34753)
2021 (37308)
2020 (33606)
2019 (23456)
2018 (17671)
2017 (19025)
2016 (18275)
2015 (24385)
2014 (21719)
2013 (18146)
2012 (20239)
2011 (20452)
2010 (20338)
Location
Africa (239)
Alabama (72)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (18132)
Australia (2117)
California (11865)
Canada (3138)
China (515)
Colorado (479)
Connecticut (405)
Delaware (209)
Europe (25237)
Florida (1771)
Georgia (371)
Hawaii (3)
Idaho (46)
Illinois (779)
India (48)
Indiana (314)
Iowa (14)
Japan (396)
Kansas (100)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1187)
Massachusetts (7804)
Michigan (306)
Minnesota (558)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2600)
New Mexico (12)
New York (2799)
North Carolina (1265)
North Dakota (4)
Northern California (5929)
Ohio (275)
Oklahoma (14)
Oregon (18)
Pennsylvania (2241)
Puerto Rico (20)
Rhode Island (30)
South America (418)
South Carolina (76)
South Dakota (1)
Southern California (4930)
Tennessee (120)
Texas (1915)
United States (38632)
Utah (357)
Vermont (1)
Virginia (153)
Washington D.C. (39)
Washington State (917)
West Virginia (1)
Wisconsin (74)
486,344 Results for "allergan inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today’s Modern Aesthetics Practices
August 11, 2026
·
9 min read
Press Releases
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
August 4, 2026
·
12 min read
Press Releases
Allergan Aesthetics launches HArmonyCa® with Lidocaine, Canada’s first dual-action, next generation collagen-stimulating injectable
May 26, 2026
·
6 min read
Press Releases
Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
June 16, 2026
·
9 min read
Press Releases
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE), for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
July 17, 2026
·
11 min read
Press Releases
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
June 23, 2026
·
15 min read
Press Releases
Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco
March 26, 2026
·
23 min read
Press Releases
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
February 18, 2026
·
5 min read
Press Releases
Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)
March 26, 2026
·
28 min read
Press Releases
Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting (AAD)
March 30, 2026
·
6 min read
1 of 48,635
Next
